More Talks Needed With China and Japan For Cooperation In Sharing Clinical Data - Korea FDA Official
This article was originally published in PharmAsia News
Executive Summary
SEOUL - Although drug regulatory officials from South Korea, Japan and China met in Beijing for two days from Dec. 17 in their second tri-party meeting, they failed to report "noticeable progress" in their pursuit of an integrated clinical trial data-sharing program and mutual acceptance of their rules and guidelines, according to Korea FDA